Hypermarcas (OTCMKTS:HYPMY) Issues Earnings Results

Hypermarcas (OTCMKTS:HYPMY) posted its quarterly earnings data on Thursday. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.13 by $0.01, Zacks reports. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.

Hypermarcas Price Performance

Shares of OTCMKTS HYPMY traded down $0.03 during midday trading on Thursday, reaching $4.13. 3,851 shares of the stock traded hands, compared to its average volume of 22,289. Hypermarcas has a one year low of $3.71 and a one year high of $5.50. The company’s 50 day moving average is $4.10 and its 200 day moving average is $4.37. The stock has a market capitalization of $2.91 billion, a PE ratio of 8.60 and a beta of 0.70.

Analysts Set New Price Targets

HYPMY has been the topic of a number of recent analyst reports. Jefferies Financial Group upgraded shares of Hypermarcas to a “strong-buy” rating in a research note on Monday, July 20th. Zacks Research upgraded Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy”.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.